Literature DB >> 17034675

Depression and anxiety.

Kimberley Miller1, Mary Jane Massie.   

Abstract

Anxiety and depression are common in patients with cancer and in palliative care settings. These symptoms can be reactive to the illness or can be related to the direct physiologic effects of the disease or to drug therapies. Effective treatment of these symptoms includes both psychopharmacologic and psychotherapeutic approaches. The newer antidepressants, anxiolytics, and hypnotics are better tolerated and can be continued safely if necessary, or they can be reduced and discontinued as symptoms improve.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034675     DOI: 10.1097/00130404-200609000-00008

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  26 in total

1.  Supportive care needs and preferences of lung cancer patients: a semi-structured qualitative interview study.

Authors:  Natasha M K Brown; Chi-Wai Lui; Peter C Robinson; Frances M Boyle
Journal:  Support Care Cancer       Date:  2014-11-14       Impact factor: 3.603

2.  Is depression an appropriate response to having cancer? A discussion of diagnostic criteria and treatment decisions.

Authors:  Anne F Gross; Felicia A Smith; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 3.  Psychopharmacology in cancer.

Authors:  Seema M Thekdi; Antolin Trinidad; Andrew Roth
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

4.  Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes.

Authors:  Laura A Bajor; Douglas Gunzler; Douglas Einstadter; Charles Thomas; Richard McCormick; Adam T Perzynski; Stephanie W Kanuch; Kristin A Cassidy; Neal V Dawson; Martha Sajatovic
Journal:  Int J Psychiatry Med       Date:  2015-06-09       Impact factor: 1.210

Review 5.  Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.

Authors:  Subash C Gupta; Ji Hye Kim; Ramaswamy Kannappan; Simone Reuter; Patrick M Dougherty; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

6.  Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.

Authors:  Mahsa M Yazdy; Allen A Mitchell; Carol Louik; Martha M Werler
Journal:  Epidemiology       Date:  2014-11       Impact factor: 4.822

7.  Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Michelle B Riba; Kristine A Donovan; Barbara Andersen; IIana Braun; William S Breitbart; Benjamin W Brewer; Luke O Buchmann; Matthew M Clark; Molly Collins; Cheyenne Corbett; Stewart Fleishman; Sofia Garcia; Donna B Greenberg; Rev George F Handzo; Laura Hoofring; Chao-Hui Huang; Robin Lally; Sara Martin; Lisa McGuffey; William Mitchell; Laura J Morrison; Megan Pailler; Oxana Palesh; Francine Parnes; Janice P Pazar; Laurel Ralston; Jaroslava Salman; Moreen M Shannon-Dudley; Alan D Valentine; Nicole R McMillian; Susan D Darlow
Journal:  J Natl Compr Canc Netw       Date:  2019-10-01       Impact factor: 11.908

8.  Depression and sexual adjustment following breast cancer in low-income Hispanic and non-Hispanic White women.

Authors:  Kysa M Christie; Beth E Meyerowitz; Rose C Maly
Journal:  Psychooncology       Date:  2010-10       Impact factor: 3.894

9.  Developing targets for public health initiatives to improve palliative care.

Authors:  Nils Schneider; Sara L Lueckmann; Franziska Kuehne; Katharina Klindtworth; Mareike Behmann
Journal:  BMC Public Health       Date:  2010-04-29       Impact factor: 3.295

10.  Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation.

Authors:  Leah M Pyter; Vanessa Pineros; Jerome A Galang; Martha K McClintock; Brian J Prendergast
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.